The Trump administration’s recent decision to reduce the number of quality and care measures for Medicare Advantage plans will result in an additional $18.6 billion directed towards health insurers over the next decade. This regulatory change, announced by the Centers for Medicare and Medicaid Services (CMS), marks a significant shift in the financial landscape for these plans.
Originally, CMS had projected a $13.2 billion cost associated with the proposed adjustments to star ratings, which were first introduced in November. The final regulation, however, has exceeded expectations, providing a more favorable outcome for the insurance sector. This influx of funding is particularly crucial as Medicare Advantage insurers face rising medical claims and are poised to receive final payment rates for 2027.
As insurers have actively lobbied for increased baseline payments and more lenient reporting requirements regarding member health conditions, this regulatory change offers a substantial financial cushion. The implications of these adjustments will be closely monitored, especially with the government set to announce further regulations by April 6.
Use the database as your supply chain compass →
